RUBICON RESEARCH

Rubicon Research is an IP led, specialty pharmaceutical company focused on our mission to provide innovative yet affordable patient-centered products and solutions so as to address unmet needs around the world. We leverage our proprietary technologies and specialized formulation development skills to provide solutions to complex delivery challenges; enabling better patient outcomes... Rubicon Research is a specialty pharmaceutical company focused on developing high quality products using innovative technologies for the global market. We are committed to designing effective value-added formulations that enrich lives around the world... 2019 was an eventful year for Rubicon Research. We received a USD 100 million growth capital commitment from General Atlantic and acquired 15 ANDAs to augment our fast-growing generic portfolio. With General Atlantic's support, Rubicon Research is expanding its R&D program and building a larger, globalized manufacturing footprint. As part of our ongoing..

Also known as: Rubicon Academy LLP, Rubicon Consumer Healthcare Private Limited, Rubicon Research Canada Limited, Rubicon Research Canada Ltd., Rubicon Research Private Limited, Rubicon Research Pvt. Ltd.

Primary location: Plainsboro United States